Effect of Hypnosis on Motor Cortex Excitability

This study has been completed.
Sponsor:
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT00416247
First received: December 26, 2006
Last updated: August 4, 2010
Last verified: December 2006

December 26, 2006
August 4, 2010
December 2006
December 2007   (final data collection date for primary outcome measure)
Cortical Excitability [ Time Frame: Before and after intervention ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00416247 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Hypnosis on Motor Cortex Excitability
Effect of Hypnosis on Motor Cortex Excitability

This study is intended to investigate neurophysiological mechanisms of hypnosis using transcranial magnetic stimulation (TMS) and assessment of motor cortex excitability in healthy volunteers under hypnosis.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Healthy
Behavioral: Hypnosis
Hypnosis
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
June 2009
December 2007   (final data collection date for primary outcome measure)

Inclusion Criteria: .

  1. Healthy volunteers aged 20 to 45 years.
  2. Hypnotisability above 14 as measured by the Tellegan absorption scale.

Exclusion Criteria:

  1. Psychiatric diagnosis in axis I or axis II;
  2. Documented history of head injury or seizure disorder;
  3. Evidence of a disorder which could affect peripheral and central conduction such as multiple sclerosis, motor neuron disease, carpal tunnel syndrome, cervical spondylosis, diabetic neuropathy.
  4. Any other contraindication to TMS as specified in the safety guidelines for rTMS (Wassermann, 1998) such as cardiac pacemakers or metallic deep brain electrodes.
  5. Chronic pharmacological treatment.
Both
20 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00416247
rambam2409_CTIL
Not Provided
Ehud Klein, MD, Head Department of Psychiatry, Rambam Medical Center
Rambam Health Care Campus
Not Provided
Principal Investigator: Ehud Klein, MD Rambam Health Care Campus
Rambam Health Care Campus
December 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP